HIGHLIGHTS
- who: David Schweer et al. from the Zealand University Hospital, Denmark have published the paper: Human macrophage-engineered vesicles for utilization in ovarian cancer treatment, in the Journal: (JOURNAL)
- future: (C) Same mice shown with clear and persistent fluorescent uptake seen in far-right mouse`s tumor. ameliorated in future studies with further filtration methods. In terms of generalization of in_vivo models SCID and nude mice are particularly immunosuppressed future modeling using syngeic murine models may more accurately reflect physiologic conditions and reveal the interplay of circulating MEVs with the immune system targets. Future research . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.